CDK2 and mantle cell lymphoma: In primary MCL cells and three MCL cell lines, ZGDHu-1 (100 - 200 ng/ml, 48 h) decreased the protein levels of cyclin D1, but not cyclin B1, cyclin E and CDK2, in dose-dependent manners (Figure 5A).